Tyrosinkinashämmare
Tyrosinkinashämmare, also known as tyrosine kinase inhibitors (TKIs), are a class of drugs used primarily in cancer treatment. They work by targeting specific proteins called tyrosine kinases, which are enzymes that play a crucial role in cell growth and division. In many cancers, these tyrosine kinases are overactive or mutated, leading to uncontrolled cell proliferation. TKIs block the activity of these enzymes, thereby inhibiting the growth and spread of cancer cells.
These targeted therapies represent a significant advancement over traditional chemotherapy, which often affects healthy cells as
The development of TKIs has revolutionized the treatment of certain hematological malignancies and solid tumors. However,